Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

GSK faces accusations of bribing doctors in Poland.

Jofre S.

BMJ. 2014 Apr 14;348:g2768. doi: 10.1136/bmj.g2768. No abstract available.

PMID:
24733722
2.

Punishing health care fraud--is the GSK settlement sufficient?

Outterson K.

N Engl J Med. 2012 Sep 20;367(12):1082-5. Epub 2012 Sep 12. No abstract available.

3.

US drug companies paid $15bn in fines for fraudulent marketing in past five years.

Tanne JH.

BMJ. 2010 Dec 21;341:c7360. doi: 10.1136/bmj.c7360. No abstract available.

PMID:
21177361
4.

Moral decay at GSK reaps record US$3 billion fine.

[No authors listed]

Lancet. 2012 Jul 7;380(9836):2. doi: 10.1016/S0140-6736(12)61110-6. No abstract available.

PMID:
22770442
5.

Doctor explains why he blew the whistle.

Petersen M.

N Y Times Web. 2003 Mar 12:C1, C2. No abstract available.

PMID:
12812161
6.

Johnson & Johnson to pay $2.2bn to settle charges of false marketing on three drugs.

Kmietowicz Z.

BMJ. 2013 Nov 6;347:f6696. doi: 10.1136/bmj.f6696. No abstract available.

PMID:
24196512
8.

Former drug execs lose appeal. Bid for re-entry to Medicare is denied.

Rhea S.

Mod Healthc. 2010 Dec 20-27;40(51):14. No abstract available.

PMID:
21344720
9.

Drug lawsuits building. Merck, Pfizer facing charges of misrepresentation.

Benko LB.

Mod Healthc. 2006 Apr 10;36(15):16. No abstract available.

PMID:
16669517
10.

Disease management and antikickback regulations.

Kozma CM.

Manag Care Interface. 2003 Dec;16(12):34-5. No abstract available.

PMID:
14750462
11.

Alleged improprieties. Trial could affect hospital-drug company relationships.

Taylor M.

Mod Healthc. 2004 May 17;34(20):20-1. No abstract available.

PMID:
15164492
12.

Former drug firm president is charged with masterminding kickback scheme for physicians.

Dyer O.

BMJ. 2015 Nov 5;351:h5968. doi: 10.1136/bmj.h5968. No abstract available.

PMID:
26542976
13.

Sanofi is investigated for allegedly bribing doctors in China.

Hawkes N.

BMJ. 2013 Aug 12;347:f5074. doi: 10.1136/bmj.f5074. No abstract available.

PMID:
23940298
14.

Former Johnson and Johnson executives are convicted over off label marketing.

Dyer O.

BMJ. 2016 Jul 27;354:i4179. doi: 10.1136/bmj.i4179. No abstract available.

PMID:
27469393
15.

Former head of GSK China is charged with bribery.

Parry J.

BMJ. 2014 May 16;348:g3356. doi: 10.1136/bmj.g3356. No abstract available.

PMID:
24838107
16.

Off-label or off-limits?

Ratner M, Gura T.

Nat Biotechnol. 2008 Aug;26(8):867-75. doi: 10.1038/nbt0808-867. No abstract available.

PMID:
18688236
17.

Pfizer to pay $430 million over promoting drug to doctors.

Harris G.

N Y Times Web. 2004 May 14:C6. No abstract available.

PMID:
15290803
18.

Enforcement actions involving Medicaid fraud and abuse, 1996-2009.

Qureshi ZP, Liu Y, Sartor O, Chu YH, Bennett CL.

Arch Intern Med. 2011 Apr 25;171(8):785-7. doi: 10.1001/archinternmed.2011.142. No abstract available.

PMID:
21518950
19.

HHS' fourth fraud alert puts spotlight on drug companies.

Burda D, Scott L.

Mod Healthc. 1994 Aug 29;24(35):26, 34. No abstract available.

PMID:
10136147
20.

Big pharma often commits corporate crime, and this must be stopped.

G√łtzsche PC.

BMJ. 2012 Dec 14;345:e8462. doi: 10.1136/bmj.e8462. No abstract available.

PMID:
23241451

Supplemental Content

Support Center